Jieyao Li
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer-related molecular mechanisms research 2
-
- Immune Cell Function and Interaction 2
-
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 2
-
- Epigenetics and DNA Methylation 3
- Wnt/β-catenin signaling in development and cancer 2
- Hedgehog Signaling Pathway Studies 1
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Immunity (1 paper)International Journal of Cancer (1 paper)Experimental Cell Research (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Jieyao Li
14 papers receiving 412 citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Cancer Research 113
- Immunology 122
- Oncology 155
- Molecular Biology 195
- Pulmonary and Respiratory Medicine 91
Countries citing papers authored by Jieyao Li
This map shows the geographic impact of Jieyao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieyao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieyao Li more than expected).
Fields of papers citing papers by Jieyao Li
This network shows the impact of papers produced by Jieyao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieyao Li. The network helps show where Jieyao Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jieyao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosisbreakdown → | 2024 | 59 |
| 2 | 2023 | 5 | |
| 3 | 2022 | 31 | |
| 4 | 2020 | 18 | |
| 5 | 2019 | 11 | |
| 6 | 2018 | 13 | |
| 7 | 2017 | 20 | |
| 8 | 2017 | 38 | |
| 9 | 2017 | 38 | |
| 10 | 2016 | 71 | |
| 11 | 2016 | 27 | |
| 12 | 2015 | 40 | |
| 13 | 2014 | 10 | |
| 14 | 2014 | 35 |
About Jieyao Li
Jieyao Li is a scholar working on Cancer Research, Oncology and Immunology, having authored 14 papers that have together received 416 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Immune Cell Function and Interaction (2 papers), Cancer Cells and Metastasis (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers) and Hedgehog Signaling Pathway Studies (1 paper). The work is most often cited by research in Cancer Research (113 citations), Immunology (122 citations) and Oncology (155 citations). Jieyao Li has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Liping Wang, Yi Zhang, Dongli Yue, Xinfeng Chen, Ping Yü, Lan Huang, Lifeng Li, Bin Zhang, Feng Li and Xiaojuan Shi. Their work appears in journals such as Immunity, International Journal of Cancer and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.